Systematic review and cost-effectiveness of pharmacokinetically guided sunitinib individualized treatment for patients with metastatic renal cell carcinoma

BACKGROUND: Sunitinib has a narrow therapeutic window, with considerable differences between patients. Dosing based on pharmacokinetics (PK) may help overcome some of those issues. This study aims to evaluate and compare the cost-effectiveness of PK-guided individualized treatment of sunitinib with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tingting, Chen, Jiahe, Chen, Chaoxin, Guo, Jianming, He, Xin, Zheng, Song, Liu, Maobai, Zheng, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972915/
https://www.ncbi.nlm.nih.gov/pubmed/35371296
http://dx.doi.org/10.1177/17588359221085212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972915/
https://www.ncbi.nlm.nih.gov/pubmed/35371296
http://dx.doi.org/10.1177/17588359221085212

Ejemplares similares